Drug intelligence / Profile preview

glycyrrhizic acid + glycine + methionine

Development stage
Unknown
Lead developer
AOP Health
Modality
Small Molecules
Administration
Oral
01

Overview

Glycyron is an oral combination drug containing monoammonium glycyrrhizate (a salt of glycyrrhizic acid), glycine, and DL-methionine. Developed by onepharm Research & Development GmbH, it is primarily investigated for the treatment of gingivitis. Glycyrrhizic acid, a triterpenoid saponin extracted from licorice root (*Glycyrrhiza glabra*), exerts anti-inflammatory effects by inhibiting 11-beta-hydroxysteroid dehydrogenase (11β-HSD), which prevents the breakdown of cortisol. It also suppresses pro-inflammatory cytokines like TNF-alpha, inhibits NF-κB nuclear translocation, and acts as an antioxidant. The addition of glycine and methionine is intended to mitigate potential side effects of glycyrrhizin, such as pseudoaldosteronism, and support hepatic function. The drug has been studied in Phase II clinical trials in Germany for adult patients with gingivitis.

Brand names
Glycyron
Other names
monoammonium glycyrrhizate + glycine + DL-methionineoral glycyrrhizin
02

Targets

HSD11B1 (11-beta-hydroxysteroid dehydrogenase type 1)HSD11B2 (11β-HSD2)CASP3 (Caspase-3)HMGB1 (High mobility group protein B1)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on glycyrrhizic acid + glycine + methionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycyrrhizic acid + glycine + methionine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call